Publication | Arterburn 2011 [21] | Jibaja-Weiss 2011 [23] | LeBlanc 2015 [24] | Mathers 2012 [27] | Mott 2014 [28] | Solberg 2010 [31] | Vandemheen 2009 [32] | |||
---|---|---|---|---|---|---|---|---|---|---|
Production Year | 2014 (update) | 2006 | 2007 | 2012 | 2008 | - | - | 2014 (update) | 2006 | 2007 |
Information | ||||||||||
 Options available | + | + | + | + | + | + | + | + | + | + |
 Positive features | + | + | + | + | + | + | + | + | + | + |
 Negative features | + | + | + | + | + | + | + | + | + | + |
 Fair comparison | + | + | + | + | + | + | + | + | + | + |
Probabilities | ||||||||||
 Reference class | + | - | + | + | + | + | + | + | + | + |
 Event rates | + | - | + | - | + | - | - | - | + | + |
 Compare probabilities | + | - | + | + | + | + | - | + | - | + |
Values | ||||||||||
 Personal importance | + | + | - | - | + | + | - | + | + | - |
Development | ||||||||||
 Patients’ needs | + | + | + | + | + | - | + | + | + | + |
 Impartial review | + | + | + | + | + | + | + | + | + | + |
 Tested with patients | - | + | + | + | + | + | + | - | - | + |
Disclosure | ||||||||||
 Information about funding | + | + | + | + | + | + | + | + | + | + |
DST evaluation | ||||||||||
 Knowledge | + | + | + | + | + | - | + | + | + | + |
 Improved decision quality | + | + | - | + | + | - | - | + | + | + |
Evidence | ||||||||||
 Citations to studies | + | + | + | + | + | - | + | + | + | + |
 Production date | + | + | + | + | + | - | - | + | + | + |
 Total | 15 | 13 | 14 | 14 | 16 | 10 | 11 | 14 | 14 | 15 |